ImmunityBio
2.25
-0.06
-2.60%
IBRX
08-25 16:00:00(美东时间)
高
2.36
开
2.31
量
729.39万股
总市值
21.27亿
低
2.23
换
0.77%
额
1653.26万
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
ImmunityBio(IBRX)
08-09 04:35
$ImmunityBio(IBRX)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-177024 Act: 34 Size: 641 KB
网页链接
ImmunityBio(IBRX)
08-05 19:45
$ImmunityBio(IBRX)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001326110-25-000114 Act: 34 Size: 15 MB
网页链接
ImmunityBio(IBRX)
08-05 19:25
$ImmunityBio(IBRX)$
8-K Current report, items 2.02 and 9.01 Accession Number: 0001326110-25-000112 Act: 34 Size: 299 KB
网页链接
ImmunityBio(IBRX)
07-28 23:15
$ImmunityBio(IBRX)$
424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-165807 Act: 33 Size: 916 KB
网页链接
ImmunityBio(IBRX)
07-25 18:25
$ImmunityBio(IBRX)$
8-K Current report, items 1.01, 2.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-164789 Act: 34 Size: 764 KB
网页链接
1赞
ImmunityBio(IBRX)
06-24 05:15
$ImmunityBio(IBRX)$
S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001326110-25-000099 Act: 33 Size: 273 KB
网页链接
ImmunityBio(IBRX)
06-21 06:45
$ImmunityBio(IBRX)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000094 Size: 5 KB
网页链接
ImmunityBio(IBRX)
06-21 06:45
$ImmunityBio(IBRX)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000093 Size: 5 KB
网页链接
ImmunityBio(IBRX)
06-21 06:45
$ImmunityBio(IBRX)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000092 Size: 5 KB
网页链接
ImmunityBio(IBRX)
06-21 06:35
$ImmunityBio(IBRX)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000090 Size: 5 KB
网页链接
ImmunityBio(IBRX)
06-21 06:35
$ImmunityBio(IBRX)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001326110-25-000091 Size: 5 KB
网页链接
ImmunityBio(IBRX)
06-21 04:45
$ImmunityBio(IBRX)$
8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001326110-25-000084 Act: 34 Size: 415 KB
网页链接
ImmunityBio(IBRX)
05-12 18:55
$ImmunityBio(IBRX)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001326110-25-000071 Act: 34 Size: 14 MB
网页链接
2转发
·
2讨论
ImmunityBio(IBRX)
05-12 18:45
$ImmunityBio(IBRX)$
8-K Current report, items 2.02 and 9.01 Accession Number: 0001326110-25-000069 Act: 34 Size: 265 KB
网页链接
ImmunityBio(IBRX)
05-05 19:25
$ImmunityBio(IBRX)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-112057 Act: 34 Size: 428 KB
网页链接
ImmunityBio(IBRX)
04-30 18:05
$ImmunityBio(IBRX)$
DEF 14A Other definitive proxy statements Accession Number: 0001326110-25-000054 Act: 34 Size: 7 MB
网页链接
ImmunityBio(IBRX)
04-30 18:05
$ImmunityBio(IBRX)$
ARS Annual Report to Security Holders Accession Number: 0001326110-25-000056 Act: 34 Size: 113 MB
网页链接
ImmunityBio(IBRX)
04-30 18:05
$ImmunityBio(IBRX)$
DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001326110-25-000059 Act: 34 Size: 432 KB
网页链接
ImmunityBio(IBRX)
04-09 04:55
$ImmunityBio(IBRX)$
424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-075804 Act: 33 Size: 821 KB
网页链接
ImmunityBio(IBRX)
04-08 19:55
$ImmunityBio(IBRX)$
8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001193125-25-075102 Act: 34 Size: 505 KB
网页链接